Form D · Pharmaceuticals
RECURSION PHARMACEUTICALS, INC.
Salt Lake City, UT · CIK 0001601830
Offering snapshot reported Nov 12, 2020 · SEC filing
- Reported sold
- $246M Offering amount: $246M
- Investors reported
- 49 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 1, 2020 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$235,506,731 → $245,896,677
- Reported investors38 → 49
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2020 | Amendment | $245,896,677 | $10,389,946vs Sep 15, 2020 | 49 | SEC filing |
| Sep 15, 2020 | Initial | $235,506,731 | No comparison | 38 | SEC filing |
| Aug 13, 2019 | Initial | $122,057,689 | No comparison | 33 | SEC filing |
| Oct 6, 2017 | Initial | $55,799,946 | No comparison | 26 | SEC filing |
| Dec 2, 2016 | Amendment | $15,034,984 | $2,124,997vs Sep 14, 2016 | 18 | SEC filing |
| Sep 14, 2016 | Initial | $12,909,987 | No comparison | 13 | SEC filing |
| Sep 14, 2016 | Initial | $4,066,996 | No comparison | 31 | SEC filing |
| Sep 14, 2016 | Initial | $32,000,000 | No comparison | 32 | SEC filing |
| Dec 4, 2015 | Initial | $2,650,000 | No comparison | 8 | SEC filing |
| Feb 23, 2015 | Initial | $830,000 | No comparison | 19 | SEC filing |
| Apr 2, 2014 | Amendment | $80,000 | $0vs Apr 2, 2014 | 5 | SEC filing |
| Apr 2, 2014 | Initial | $80,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-375551
Source: Form D, filed Nov 12, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Zachary Bogue | Director |
| Blake C. Borgeson | Director |
| Terry Ann Burrell | Director |
| R. Martin Chavez | Director |
| Zavain Dar | Director |
| Perry Fell | Director |
| H. Perry Fell | Director |
| Christopher C. Gibson | Director, Executive, Promoter |
| Robert Hershberg | Director |
| Reid Hutchins | Director |
| Dean Li | Director |
| John Pereira | Executive |
| Michael Secora | Executive, Promoter |
| Dean Y. Yi | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
41 S Rio Grande Street
Salt Lake City, UT, 84101
Salt Lake City, UT, 84101